Comparison of Data on Serious Adverse Events and Mortality in ClinicalTrials.gov, Corresponding Journal Articles, and FDA Medical Reviews: Cross-Sectional Analysis

Overview of attention for article published in Drug Safety, April 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 14 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 12 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 16 X posts from 14 X users, with an upper bound of 31,228 followers.

RT @sanoysalvoblog: (Drug Safety) There are differences in data on rates of serious adverse events and mortality in randomized clinical tri…

Reply Repost Favourite

RT @sanoysalvoblog: (Drug Safety) There are differences in data on rates of serious adverse events and mortality in randomized clinical tri…

Reply Repost Favourite

RT @sanoysalvoblog: (Drug Safety) There are differences in data on rates of serious adverse events and mortality in randomized clinical tri…

Reply Repost Favourite

(Drug Safety) There are differences in data on rates of serious adverse events and mortality in randomized clinical trials in both https://t.co/AbnR8hNyxT and journal articles compared with FDA reviews https://t.co/aLETTyTvPq #Transparency #PtSafety via sa

Reply Repost Favourite

(Drug Safety) There are differences in data on rates of serious adverse events and mortality in randomized clinical trials in both https://t.co/oB04O61D6T and journal articles compared with FDA reviews https://t.co/rxvkYOvvKG #Transparency #PtSafety

Reply Repost Favourite

RT @DrugSafetyJ: Study found deviations in rates of serious adverse events/mortality in https://t.co/ENhzDGoKsC and corresponding journal a…

Reply Repost Favourite

RT @DrugSafetyJ: Study found deviations in rates of serious adverse events/mortality in https://t.co/ENhzDGoKsC and corresponding journal a…

Reply Repost Favourite

RT @DrugSafetyJ: Study found deviations in rates of serious adverse events/mortality in https://t.co/ENhzDGoKsC and corresponding journal a…

Reply Repost Favourite

RT DrugSafetyJ: Study found deviations in rates of serious adverse events/mortality in https://t.co/AbnR8hNyxT and corresponding journal articles when compared with the reference standard (FDA medical reviews) #pharmacovigialnce https://t.co/aLETTyTvPq htt

Reply Repost Favourite

RT @DrugSafetyJ: Study found deviations in rates of serious adverse events/mortality in https://t.co/ENhzDGoKsC and corresponding journal a…

Reply Repost Favourite

RT @DrugSafetyJ: Study found deviations in rates of serious adverse events/mortality in https://t.co/ENhzDGoKsC and corresponding journal a…

Reply Repost Favourite

RT @DrugSafetyJ: Study found deviations in rates of serious adverse events/mortality in https://t.co/ENhzDGoKsC and corresponding journal a…

Reply Repost Favourite

Fancy that https://t.co/R3A0qBQmhs

Reply Repost Favourite

RT @DrugSafetyJ: Study found deviations in rates of serious adverse events/mortality in https://t.co/ENhzDGoKsC and corresponding journal a…

Reply Repost Favourite

RT @DrugSafetyJ: Study found deviations in rates of serious adverse events/mortality in https://t.co/ENhzDGoKsC and corresponding journal a…

Reply Repost Favourite

Study found deviations in rates of serious adverse events/mortality in https://t.co/ENhzDGoKsC and corresponding journal articles when compared with the reference standard (FDA medical reviews) #pharmacovigialnce https://t.co/WOj4T427pk https://t.co/7ZF8Su

Reply Repost Favourite